Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of group A and C meningococcal conjugate vaccine in infants
CTR20170710Phase 2Active
- Sponsor
- Sinopharm
- Start
- Aug 2017
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of meningococcal A+C conjugate vaccine in meningococcal meningitis, meningococcal disease, invasive meningococcal disease (IMD), sponsored by Sinopharm. Started Aug 2017; status: active.
02
Drugs
meningococcal A+C conjugate vaccine
03
Conditions
meningococcal meningitismeningococcal diseaseinvasive meningococcal disease (IMD)
Beyond the preview
Go deeper on CTR20170710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170710.